Habil Khorakiwala-led health care major Wockhardt is planning to globally introduce antibiotics that may help contain the problem of anti-microbial drug resistance.
The Mumbai-based drug maker has sought the Centre’s intervention to seek funding from G-20 countries, an international forum of governments for development of the portfolio, a top government official told Business Standard.
The antibiotic has been in the making for the last two decades. Currently, it’s learnt to be at an advanced stage of development.
While the investment made has not been divulged, estimates suggest that a similar drug development in the US could mean an investment of